Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

Experimental TB Vaccine For HIV-Positive People Enters Phase II Clinical Trials

April 15, 2010

Biopharmaceutical company Crucell and the Aeras Global Tuberculosis Vaccine Foundation announced the start of "Phase II clinical trial of a tuberculosis-vaccine candidate targeted at adults infected with HIV," MarketWatch reports. Trials will test the "safety and efficacy of Aeras 402/Crucell Ad35" and will be led by the Aurum Institute in Klerksdorp, South Africa (Daniel, 4/14).

Back to other news for April 2010


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
Tuberculosis (TB) Fact Sheet
Questions and Answers About Tuberculosis
More on Tuberculosis Prevention and Diagnosis in HIV-Positive Patients

Tools
 

Advertisement